Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Camp4 Therapeutics (CAMP) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to 1717.11%.

  • Camp4 Therapeutics' EBIT Margin changed N/A to 1717.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 1415.39%, marking a year-over-year change of. This contributed to the annual value of 8142.33% for FY2024, which is 66802400.0% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported EBIT Margin of 1717.11% as of Q3 2025.
  • Camp4 Therapeutics' EBIT Margin's 5-year high stood at 870.27% during Q2 2025, with a 5-year trough of 3525.14% in Q3 2023.
  • For the 3-year period, Camp4 Therapeutics' EBIT Margin averaged around 1958.36%, with its median value being 1717.11% (2025).